How Our Rebrand Enables Support for Clinics and Prospective Parents

Cryoport Systems entered the market over two decades ago to support the logistics processes of life sciences organizations. As industry demands evolved, our focus on supporting biopharma logistics expanded to the human reproductive medicine market through our robust platform of supply chain management offerings. Now in 2024, we’re reemerging with a rebrand that touches all Cryoport, Inc. companies, reflecting our organization’s evolution that integrates seamlessly with our trusted services. 

To expand on this recent change, we want to discuss some important questions about the meaning behind our rebrand. Let’s explore who Cryoport Systems is today and how we’ll continue to support prospective parents and clinic journeys into the future.  

What does our rebrand represent? 

Prospective parents and their chosen clinics deal in possibility, variability, and uncertainty on a daily basis. From storing gametes to transporting sensitive reproductive materials internationally, Cryoport Systems has always placed emphasis on our client-centric processes and solutions. This rebranding marks our consistent approach to support certainty throughout a person’s reproductive medicine journey. 

Our new tagline, Enabling the Outcome, is a succinct way of defining our rebranding. The clinics we support work to enable prospective parents’ fertility options with personalized procedures and care. In turn, Cryoport Systems comes alongside both clinics and prospective parents to be the guiding hand in navigating transport and storage options. We work to enable prospective parents towards their fertility goals through our personalized support of their defined outcome. 

How does Cryoport Systems Enable the Outcome? 

As mentioned, Cryoport Systems isn’t the logistics company that we once were. The development of our platform of supply chain solutions connects our ability to support the market through every step of your material transport journey. Our unique processes and services include:  

  • International Shipping Support – An expert team of professionals with vast knowledge of international shipping regulations who can assist with customs clearance. 
  • Veri-Clean® Our validated, one-of-a-kind cleaning and disinfection process of all cryo-shippers and stainless-steel accessories that works to ensure the integrity and purity of shipments. 
  • Cryoportal® 2 – The industry’s most innovative logistics management system, which provides clinics with 24/7/365 monitoring, comprehensive visibility, and meticulous traceability of the sensitive material transport process. 

Our advanced solutions allow us to enable our clients’ journeys through logistics and specialized services not offered by other providers. Our platform of solutions and decades of experience make Cryoport Systems the single provider for sensitive material transport and storage solutions whose focus on risk mitigation extends through every step in the transport and storage process. 

What is Cryoport Systems’ vision for the future? 

Whether it be the diversification of our services, the launch of new solutions, or our growing number of locations, advancement and evolution are central to our organization’s pathway into the future. In recent history, our expertise was an integral part in the development of ISO 21973:2020, titled General Requirements for Transportation of Cells for Therapeutic Use. While specific to the transport of cell and gene therapies, ISO 21973:2020 sets the stage for future reproductive medicine transport regulations to help support the possibility of risk-free sensitive material shipping for all material types. Enabling the outcome extends to our voice in the reproductive medicine industry for the advancement of regulations towards standardizing safety. 

Additionally, Cryoport Systems is part of a global family of companies all under Cryoport, Inc. Our network of sister companies plays an integral part in how our platform of solutions can serve the industry. As our global family of companies grows, we can offer a wider and deeper level of services across the Americas, Europe, and APAC regions. Our network mitigates risk and provides a seamless platform that supports our clients’ journeys both domestically and internationally. 



Cryoport Systems wants to help enable your outcome within the reproductive medicine industry. For more information on our services and proficiencies, check out these resources on our website. To see the unveiling of our rebrand at Nasdaq MarketSite, check out our recent blog post.